Also found in: Medical, Wikipedia.
MEDAEuro - Mediterranean Partnership
MEDAMennonite Economic Development Associates
MEDAMission Economic Development Association (San Francisco, CA)
MEDAMaintenance Error Decision Aid (Boeing)
MEDAMassachusetts Eating Disorder Association, Inc.
MEDAMolecular Electronics Design Automation
MEDAMicroEnterprise Development Association
MEDAMetro Economic Development Alliance (Jackson, Mississippi)
MEDAMobile Environmental Data Acquisition (Mobile, autonomous data gathering technique)
References in periodicals archive ?
14 April 2011 - Carnegie has increased its share price target and confirmed its "outperform" rating on Swedish pharma company Meda AB (STO: MEDA A), while SEB Enskilda has cut its recommendation to "hold" from "buy".
8 April 2011 - Bank of America/Merrill Lynch upgraded on Friday its share price target on Swedish pharma company Meda AB (STO: MEDA A) to SEK71 from SEK63 and maintained a "buy" rating based on Meda's recent acquisitions.
30 March 2011 - Swedish pharma company Meda AB (STO: MEDA A) said today its anti-epileptic drug candidate Trobalt (retigabine) had been granted marketing approval in the European Union (EU) by the European Commission.
st), a research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has renegotiated the terms of its commercial partnership with Meda (OMX: MEDA A), a specialty pharmaceutical company, for Xerese, Medivir's unique marketed product for cold sores (herpes labialis).
14 February 2011 - Swedish pharma company Meda AB (STO: MEDA A) proposed a doubled dividend of SEK2.
23 December 2010 - Swedish pharma company Meda AB (STO: MEDA A) will take over the distribution in Europe of allergy drug Epipen Auto-Injector from 2011 under a long-term licence agreement with Dey Pharma, part of US-based Mylan Inc (NASDAQ: MYL).